Molecular Diagnostics
Molecular IVD Assay Identifies Women at High Risk for Cervical Cancer
A new molecular assay that has been demonstrated as a sensitive follow-up test to identify HPV positive women with progressing cervical disease in direct need for colposcopy or other follow-up procedures will help to identify women at high risk for cervical cancer. More...12 Oct 2022
Fragile X Syndrome Mutations Found With Comprehensive Testing Method
Fragile X syndrome (FXS), the most common form of inherited intellectual disability and monogenic cause of autism spectrum disorders, is mainly caused by the expansion of CGG trinucleotide repeats in the 5′ untranslated region of FMR1 gene. More...10 Oct 2022
Genetic Prognosis Explored for Pediatric Dilated Cardiomyopathy
Dilated cardiomyopathy (DCM) in children is a disease in which, due to abnormalities in the muscle, one or both ventricles in a child’s heart become enlarged and contract poorly. A variety of processes that result in myocardial damage can lead to dilated cardiomyopathy and coronary artery disease. More...10 Oct 2022
Highly Sensitive Biosensing Technology Diagnoses Alzheimer’s Disease in Blood
Scientists have developed a biosensing technology that can detect amyloid β (Aβ)-binding exosomes in the blood of mice, which increase as Aβ accumulates in the brain - one of the primary causes of Alzheimer’s disease. More...10 Oct 2022
A Novel Gene Signature Predicts Likelihood of Neuroblastoma Relapse
Cancer researchers identified distinct circulating tumor cell and disseminated tumor cell gene expression signatures that distinguished neuroblastoma patients with bone marrow metastases at initial diagnosis, and that persisted in patients with subsequent relapse. More...07 Oct 2022
State-Of-The-Art POC Molecular System to Allow Untrained Operators to Perform Testing for Viral and Bacterial Pathogens
DiaSorin (Saluggia, Italy) has announced that DiaSorin Molecular LLC will collaborate with the Biomedical Advanced Research and Development Authority (BARDA), to support the FDA 510(k) clearance of a CLIA-waived molecular solution for infectious disease testing. More...07 Oct 2022
Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
In Other News
Blood Test to Screen for Fungus May Offer Brand-New Method for Early Cancer Detection
Molecular Test Accurately Classifies Pancreatic Cysts as Potentially Cancerous or Benign
New Insights into Molecular Interactions Pave Way for Rapid AKI Diagnostic Tests
Next-Gen Ebola Test to Offer Improved Sensitivity and More Automation
Troponin Testing Could Improve Timing of Heart Surgery and Survival Rate
Simple Blood Draw Could Revolutionize Early Breast Cancer Detection
Liquid Biopsy Testing Platform Offers Unprecedented Sensitivity for MRD Detection
New Avenues for Use of Single-Molecule Detection Assays in Clinical Diagnosis
Single Blood Test Enables Early Detection of Multiple Cancer Types
World's First Sensitive and Specific Diagnostic Test to Diagnose Acute Rheumatic Fever
Novel Biomarker Predicts Response to Therapy in Patients with a Rare Form of Metastatic Colorectal Cancer
CDH1 Overexpression Predicts Early-Stage Bladder Cancer
Biosensor Detects Brain Tumors with Less Than a Drop of Blood
Mindray Launches High-Sensitivity and High-Specificity ToRCH Panel
Single Blood Test Predicts Risk of Multiple Diseases Simultaneously Using AI
Simple Blood Test Prior to CAR T-Cell Therapy Could ID Patients at Risk for Neurotoxicity
A Single-Cell RNA-Sequencing-Based Non-Invasive Screening Tool for Endometriosis
Bioperfectus Launches New MPXV Detection Kits for Better Control of Monkeypox Virus Outbreak
New Diagnostic Tool Reads Fracture Risk in Drop of Blood
Simple Blood and Urine Test Can Help Patients with Chronic Kidney Disease
New Biomarkers to Help Gauge Response of Melanoma Patients to Immune Checkpoint Therapy
Ultima Genomics Sequencer for Single-Cell RNA-Seq Evaluated
AI-Enabled POC Device Detects Cancers Without Biopsies
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.